Literature DB >> 7379281

Histology of the persistent ductus arteriosus in cases of congenital rubella.

A C Gittenberger-de Groot, A J Moulaert, J F Hitchcock.   

Abstract

Histologic study of the persistent ductus arteriosus in case of a congenital rubella syndrome revealed that this persistency is probably due to an arrest in the development of the ductus. Histologically, it resembles a very immature ductus and not the most common type of persistent ductus arteriosus. The earlier finding, that in the human ductus arteriosus, the presence of an extensive subendothelial elastic lamina is incompatible with anatomic sealing, still holds.

Entities:  

Mesh:

Year:  1980        PMID: 7379281     DOI: 10.1161/01.cir.62.1.183

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  5 in total

1.  Microtubule-associated protein 1 light chain 3 is a fibronectin mRNA-binding protein linked to mRNA translation in lamb vascular smooth muscle cells.

Authors:  B Zhou; N Boudreau; C Coulber; J Hammarback; M Rabinovitch
Journal:  J Clin Invest       Date:  1997-12-15       Impact factor: 14.808

2.  Patent ductus arteriosus: an overview.

Authors:  James E Dice; Jatinder Bhatia
Journal:  J Pediatr Pharmacol Ther       Date:  2007-07

3.  The ductus arterious and associated cardiac anomalies in interruption of the aortic arch.

Authors:  A Oppenheimer-Dekker; A C Gittenberger-de Groot; H Roozendaal
Journal:  Pediatr Cardiol       Date:  1982       Impact factor: 1.655

4.  Severe subaortic stenosis associated with congenital rubella syndrome: palliation by percutaneous transcatheter device occlusion of a patent ductus arteriosus.

Authors:  J W Moore; C E Mullins
Journal:  Pediatr Cardiol       Date:  1986       Impact factor: 1.655

5.  Myocardin regulates expression of contractile genes in smooth muscle cells and is required for closure of the ductus arteriosus in mice.

Authors:  Jianhe Huang; Lan Cheng; Jian Li; Mary Chen; Deying Zhou; Min Min Lu; Aaron Proweller; Jonathan A Epstein; Michael S Parmacek
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.